ArticleBMC cancer2023

HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.

Joris B W Elbers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.